Swiss big pharma settles patent dispute with Insulet

12-07-2022

Swiss big pharma settles patent dispute with Insulet

Marlon Trottmann / Shutterstock.com

The dispute over a patent covering a blood glucose level monitor ends with a multimillion-dollar payment and a licence agreement.


Roche, Insulet, patent infringement, settlement, medical devices, blood glucose, insulin

LSIPR